Addiction medicine across the life-spectrum (including substance use and substance use disorder treatment in adolescents and young adults), addiction medicine in office-based and hospital-based settings
My current research leverages traditional health services research methods, community-engaged research methods, and implementation science to build health equity for marginalized and racially minoritized populations who use drugs. My work focuses on examining how best to integrate harm reduction into primary care and hospital-based settings, how to develop low threshold models of care to improve engagement and retention of often marginalized and racially and ethnically minoritized populations, how to improve engagement and retention of adolescents and young adults in opioid use disorder treatment, and how to improve delivery of HIV prevention and treatment services to people across across the life spectrum.
Selected Publications
Donohue JM, Wang B, Tang L, Kim JY, Junker S, Cole ES, Chang CH, Roberts E, Wilson JD, Essien UR, Gifford K, Hammerslag L, Talbert J, Ahrens K, Idala D, Mohamoud S, Clark S, Austin A, Ware O, Tossone K, Mack A, Fry C, Gordon AJ, Barnes A, Marks S, Cunningham P, Allen L, Burns M, Kennedy S. : Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020. J Subst Use Addict Treat Aug 2026.
Multidisciplinary Perspectives on a New Hospital Addiction Consult Service: A Mixed- Methods Study. : Davis MH, Tolbert J, Nessen S, Perez A, Henderson K, Durkin B, Chertok J, Perrone J, French R, McFadden R, Thakrar A, Huo S, Wilson JD, Aronowitz S, Lowenstein M. Res Sq Dec 2025.
Adams ET, Lefebvre RC, Christopher MC, Stack E, Peng L, Becker M, Behrends CN, Goldman J, Guzman Herrera MM, Hassan H, Kapler S, Jeremiah A, Augustine E, Borquez A, Wagner KD, Sherman SG, Wilson JD, Kral AH, Jordan A, Oga E, Southwell BG, Zibbell JE, Cance JD.: One voice and vision: How the RISE network built a collective identity as the foundation for strategic dissemination. Harm Reduction J Dec 2025.
Wilson JD, Klipp SP, Leon K, Liebschutz JM, Merlin J, Murray-Krezan C,
Nolette S, Phillips KT, Stein M, Weinstock N, Hamm M.: "To not feel fake, it
can't be fake": co-creation of a harm reduction, peer-delivered, health-system
intervention for people who use drugs. Harm Reduct J Jun 2025.
Leon K, Weger R, Weinstock N, Jawa R, Wilson JD.: "It's nothing personal": understanding barriers to relational harm reduction practices during inpatient hospitalization. Harm Reduct J. Jun 2025.
Salay M, Edwards KA, Winstanley EL, Bachrach RL, Bulls HW, Hanmer J, Liebschutz JM, Robbins J, Wilson JD, Yu L, Merlin JS, Murray-Krezan C.: Study Protocol for Pain Self-Management and Patient-Oriented Buprenorphine Dosing for Pain and Retention in Office-Based Opioid Treatment: A Hybrid Type 1, 2 × 2 Factorial Randomized Controlled Trial. Subst Use Addctn J Jan 2025.
Saavedra LM, Christopher MC, Illei D, Kral AH, Ray B, Zibbell JE, Wagner KD, Borquez A, Jordan A, Seal D, Cerdá M, Mackesy-Amiti ME, Wilson JD, Pho MT, Behrends CN, Hassan H, Tomko C, Oga E, Cance JD. : Advancing research on strategies to reduce drug use and overdose-related harms: a community informed approach to establishing common data elements. Harm Reduct J. October , 2025.
Hamm M, Wilson JD, Lee YJ, Norman N, Winstanley EL, McTigue KM. : Substance use as subtext to health narratives: Identifying opportunities for improving carefrom community member perspectives. Patient Educ Couns. Nov 2024.
Weger R, Weinstock N, Jawa R, Wilson JD. : "We're Not Gonna Aid You in Shooting
Up": Stigma's Relationship to Harm Reduction in People Who Inject Drugs. J Gen
Intern Med. Oct 2024.
O'Brien C, Klipp S, Jawa R, Wilson JD: Community pharmacists' attitudes toward and practice of pharmacy-based harm reduction services in Pittsburgh, PA: a descriptive survey. Harm Reduct J 21(1), Jul 2024.
back to top
Last updated: 07/02/2026
The Trustees of the University of Pennsylvania
